Clicky

Rocket Pharmaceuticals, Inc.(RCKT) News

Date Title
Sep 10 Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
Sep 9 Rocket Stock Down More Than 30% in Past Six Months: Here's Why
Aug 25 Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks
May 10 Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
May 7 Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
May 6 Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
Apr 30 Rocket Pharmaceuticals (RCKT) Upgraded to Buy: Here's Why
Apr 24 Should You Retain Your Conviction in Rocket Pharmaceuticals (RCKT)?
Apr 3 EMA Accepts Rocket (RCKT) Gene Therapy Filing for Fanconi Anemia
Apr 2 Rocket Pharmaceuticals Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia
Mar 27 Why Is Rocket Pharmaceuticals (RCKT) Down 13.6% Since Last Earnings Report?
Mar 26 Rocket Pharmaceuticals Announces Appointment of Aaron Ondrey as Chief Financial Officer and Additional Updates to Corporate Leadership Team
Dec 15 11 Most Promising Biotech Stocks to Buy According to Analysts
Dec 12 Rocket Pharmaceuticals Appoints R. Keith Woods to Board of Directors
Nov 6 Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
Nov 5 With This Rally, Rocket Just Might Take Off
Nov 2 Rocket Pharmaceuticals Stock Sees Improved Price Strength
Oct 2 Rocket Pharmaceuticals Announces FDA Acceptance of Biologics License Application with Priority Review for RP-L201 (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Sep 13 These Stocks Are Moving the Most Today: Apple, BP, Ford, NIO, Rocket Pharmaceuticals, and More
Sep 13 Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock